SetPoint Medical
PrivateLast Round
Series D
Aug 11, 2025
Est. Valuation
$650M
Total Funding Raised
$379.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SetPoint Medical operates in Healthcare & Life Sciences and is based in Valencia, California. Its latest recorded funding round was a Series D round in August 2025.
SetPoint Medical is a medical technology company that develops implantable bioelectronic devices designed to modulate neuroimmune pathways for treating chronic autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SetPoint Medical Comparables
Compare SetPoint Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 75% | |
| Nēsos Corp. | 72% | |
| Boomerang Medical | 72% |
For institutional investors. Book with your work email.
SetPoint Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 11, 2025 | ||||
| Series C Extension | Aug 11, 2025 | ||||
| VC Round | Jan 19, 2023 | ||||
| Series C | Jan 19, 2023 | ||||
| Debt | Jul 13, 2021 | ||||
VC Round | Jan 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SetPoint Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Runway Growth Capital | Debt, Series C |
| Ascendum Capital | Series D, Series C Extension |
| Sprig Equity | Series D |
| New Enterprise Associates | Series D, Series C, Series C Extension, VC Round |
| Topspin Consumer Partners | Series C Extension, Series B, Series C |
| Ally Bridge Group | Series D |
| Gilmartin Capital | Series D, Series C, Series C Extension, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 62% MoM, from 9.4K to 15.1K.
- Jun 24, 2026
Grew 29% QoQ, from 93 to 120 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 27, 2026
SetPoint Medical appoints Dan Dearen to its Board of Directors in California on Oct 27th '26, adding his nearly 40 years of medical device and life sciences leadership experience as it scales its commercial operations and advances its pipeline.
- hiresOct 27, 2026
SetPoint Medical appoints Dan Dearen to its Board of Directors in California on Oct 27th '26, adding his nearly 40 years of executive leadership experience in the medical device and life sciences industries.
- recognized_asOct 7, 2026
Fast Company names SetPoint Medical to its 2026 Next Big Things in Tech list as a Health and Medicine honoree for the SetPoint System in California on Oct 7th '26.
- recognized_asOct 7, 2026
On Oct 7th '26 in California, Fast Company selects SetPoint Medical as a Next Big Things in Tech honoree in the Health and Medicine category for its SetPoint System, an FDA-approved neuroimmune modulation device for adults with moderately to severely active rheumatoid arthritis.
- partners_withSep 28, 2026
SetPoint Medical partners with Global Neurosciences Institute as a surgical partner, enabling patients across Southern New Jersey, Delaware, and Eastern Pennsylvania to access SetPoint Therapy through regional rheumatology practices.
For institutional investors. Book with your work email.
SetPoint Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SetPoint Medical's valuation, stock price, and market status.
Is SetPoint Medical a public or private company?
SetPoint Medical is a private company.
What is the current stock price of SetPoint Medical?
SetPoint Medical is a private company, so its shares have no public market price. Caplight tracks SetPoint Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SetPoint Medical worth (valuation)?
SetPoint Medical's valuation is estimated at $650.0M based on funding round data.
Can I buy SetPoint Medical stock?
SetPoint Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SetPoint Medical's last funding round?
SetPoint Medical's most recent funding round was Series D on August 11, 2025.
Who are the main investors in SetPoint Medical?
Key investors in SetPoint Medical include New Enterprise Associates, Ally Bridge Group, Flare Capital Partners, Norwest Venture Partners, Viking Global Investors.
Will SetPoint Medical IPO soon?
No public IPO plans have been announced for SetPoint Medical.
How can I track SetPoint Medical secondary market activity?
Caplight tracks bids, offers, and trades in SetPoint Medical's shares on secondary markets.